INDV
$34.77+2.66%
Indivior Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.2% of IWMNasdaq Composite · 0.010% of ONEQUS Stock Market · 0.007% of VTIRussell 3000 · 0.007% of IWV
Indivior Pharmaceuticals Inc. monthly returns
Indivior Pharmaceuticals Inc. has averaged 5.85% per month, positive in 56% of months. Month-by-month returns for Indivior Pharmaceuticals Inc. (INDV) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+5.9%
142 months
Best month
+562.0%
Oct 2022
Worst month
-59.9%
Apr 2019
Positive months
56%
of all months
Indivior Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -3.0% | |
| Sep 2026 | +2.6% | |
| Aug 2026 | -12.7% | |
| Jul 2026 | -2.5% | |
| Jun 2026 | +13.9% | |
| May 2026 | -2.1% | |
| Apr 2026 | +20.7% | |
| Mar 2026 | -6.8% | |
| Feb 2026 | -7.5% | |
| Jan 2026 | -1.4% | |
| Dec 2025 | +6.8% | |
| Nov 2025 | +14.4% | |
| Oct 2025 | +21.8% | |
| Sep 2025 | -0.7% | |
| Aug 2025 | +20.2% | |
| Jul 2025 | +37.0% | |
| Jun 2025 | +14.6% | |
| May 2025 | +11.7% | |
| Apr 2025 | +20.8% | |
| Mar 2025 | +3.1% | |
| Feb 2025 | -22.4% | |
| Jan 2025 | -4.3% | |
| Dec 2024 | +10.9% | |
| Nov 2024 | +24.4% | |
| Oct 2024 | -7.6% | |
| Sep 2024 | -22.0% | |
| Aug 2024 | -9.1% | |
| Jul 2024 | -14.7% | |
| Jun 2024 | -12.0% | |
| May 2024 | +4.3% | |
| Apr 2024 | -18.0% | |
| Mar 2024 | -0.0% | |
| Feb 2024 | +21.5% | |
| Jan 2024 | +15.5% | |
| Dec 2023 | -9.8% | |
| Nov 2023 | -7.9% | |
| Oct 2023 | -20.3% | |
| Sep 2023 | +3.7% | |
| Aug 2023 | +0.0% | |
| Jul 2023 | -6.6% | |
| Jun 2023 | +31.3% | |
| May 2023 | -3.3% | |
| Apr 2023 | +11.9% | |
| Mar 2023 | -10.9% | |
| Feb 2023 | -22.5% | |
| Jan 2023 | +11.6% | |
| Dec 2022 | +3.4% | |
| Nov 2022 | +5.9% | |
| Oct 2022 | +562.0% | |
| Sep 2022 | -13.5% | |
| Aug 2022 | -8.0% | |
| Jul 2022 | +1.9% | |
| Jun 2022 | -10.2% | |
| May 2022 | +1.7% | |
| Apr 2022 | +8.0% | |
| Mar 2022 | +4.2% | |
| Feb 2022 | +22.4% | |
| Jan 2022 | -14.8% | |
| Dec 2021 | +9.9% | |
| Nov 2021 | -7.4% | |
| Oct 2021 | +16.5% | |
| Sep 2021 | +10.0% | |
| Aug 2021 | +14.0% | |
| Jul 2021 | +10.0% | |
| Jun 2021 | -1.9% | |
| May 2021 | +1.4% | |
| Apr 2021 | +22.9% | |
| Mar 2021 | -4.2% | |
| Feb 2021 | +2.9% | |
| Jan 2021 | +19.5% | |
| Dec 2020 | +6.2% | |
| Nov 2020 | +2.2% | |
| Oct 2020 | -3.6% | |
| Sep 2020 | -9.3% | |
| Aug 2020 | -11.8% | |
| Jul 2020 | +69.9% | |
| Jun 2020 | +28.7% | |
| May 2020 | +26.4% | |
| Apr 2020 | +5.5% | |
| Mar 2020 | +13.6% | |
| Feb 2020 | +6.0% | |
| Jan 2020 | -4.2% | |
| Dec 2019 | -7.6% | |
| Nov 2019 | +4.1% | |
| Oct 2019 | -5.6% | |
| Sep 2019 | -19.4% | |
| Aug 2019 | +11.1% | |
| Jul 2019 | +25.2% | |
| Jun 2019 | -5.2% | |
| May 2019 | +12.1% | |
| Apr 2019 | -59.9% | |
| Mar 2019 | -12.4% | |
| Feb 2019 | -8.1% | |
| Jan 2019 | +10.4% | |
| Dec 2018 | +8.0% | |
| Nov 2018 | -47.3% | |
| Oct 2018 | -2.1% | |
| Sep 2018 | -31.2% | |
| Aug 2018 | -12.1% | |
| Jul 2018 | -20.7% | |
| Jun 2018 | -21.2% | |
| May 2018 | +1.7% | |
| Apr 2018 | +12.5% | |
| Mar 2018 | +8.3% | |
| Feb 2018 | -8.7% | |
| Jan 2018 | +2.9% | |
| Dec 2017 | +13.4% | |
| Nov 2017 | -3.0% | |
| Oct 2017 | +12.3% | |
| Sep 2017 | -17.6% | |
| Aug 2017 | +5.9% | |
| Jul 2017 | +25.0% | |
| Jun 2017 | -2.9% | |
| May 2017 | +1.9% | |
| Apr 2017 | +3.8% | |
| Mar 2017 | -8.1% | |
| Feb 2017 | +18.7% | |
| Jan 2017 | +2.5% | |
| Dec 2016 | -13.0% | |
| Nov 2016 | +5.2% |
Monthly total return (since Nov 2021)#
-400%-200%0%200%400%
Nov 2021-7.4%
Dec 2021+9.9%
Jan 2022-15%2022
Feb 2022+22%
Mar 2022+4.2%
Apr 2022+8.0%
May 2022+1.7%
Jun 2022-10%
Jul 2022+1.9%
Aug 2022-8.0%
Sep 2022-14%
Oct 2022+562%
Nov 2022+5.9%
Dec 2022+3.4%
Jan 2023+12%2023
Feb 2023-23%
Mar 2023-11%
Apr 2023+12%
May 2023-3.3%
Jun 2023+31%
Jul 2023-6.6%
Aug 2023+0.04%
Sep 2023+3.7%
Oct 2023-20%
Nov 2023-7.9%
Dec 2023-9.8%
Jan 2024+16%2024
Feb 2024+21%
Mar 2024-0.05%
Apr 2024-18%
May 2024+4.3%
Jun 2024-12%
Jul 2024-15%
Aug 2024-9.1%
Sep 2024-22%
Oct 2024-7.6%
Nov 2024+24%
Dec 2024+11%
Jan 2025-4.3%2025
Feb 2025-22%
Mar 2025+3.1%
Apr 2025+21%
May 2025+12%
Jun 2025+15%
Jul 2025+37%
Aug 2025+20%
Sep 2025-0.7%
Oct 2025+22%
Nov 2025+14%
Dec 2025+6.8%
Jan 2026-1.4%2026
Feb 2026-7.5%
Mar 2026-6.8%
Apr 2026+21%
May 2026-2.1%
Jun 2026+14%
Jul 2026-2.5%
Aug 2026-13%
Sep 2026+2.6%
Oct 2026-3.0%
Indivior Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -3.01% — 7th of 12 Octobers since 2015 at the last close; the average October returned +51.4%.
| Month | −565%0+565% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +2.2% | +2.7% | 58% | +19.5% 2021 | -23.5% 2016 | |
| Feb | +1.2% | +3.0% | 58% | +22.4% 2022 | -22.5% 2023 | |
| Mar | -0.8% | -0.0% | 42% | +13.6% 2020 | -12.4% 2019 | |
| Apr | +3.8% | +9.4% | 83% | +22.9% 2021 | -59.9% 2019 | |
| May | +6.5% | +1.8% | 83% | +26.4% 2020 | -3.3% 2023 | |
| Jun | +6.0% | +0.6% | 50% | +34.2% 2016 | -21.2% 2018 | |
| Jul | +12.4% | +8.6% | 67% | +69.9% 2020 | -20.7% 2018 | |
| Aug | -0.9% | -4.0% | 50% | +20.2% 2025 | -16.3% 2015 | |
| Sep | -8.5% | -7.9% | 33% | +10.0% 2021 | -31.2% 2018 | |
| Oct | +51.4% | -2.1% | 36% | +562.0% 2022 | -20.3% 2023 | |
| Nov | -1.6% | +2.2% | 55% | +24.4% 2024 | -47.3% 2018 | |
| Dec | +2.0% | +6.2% | 64% | +13.4% 2017 | -13.0% 2016 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from INDV's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Indivior Pharmaceuticals Inc.'s average monthly return?
- Indivior Pharmaceuticals Inc. (INDV) has averaged about 5.85% per month, positive in roughly 56% of months. The best month was Oct 2022 (+562.0%) and the worst was Apr 2019 (-59.9%).
More on Indivior Pharmaceuticals Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100